2023, Number 1
Digestive manifestations in patients with COVID-19
Full text
Language: Spanish
References: 31
Page: 1-14
PDF size: 424.22 Kb.
ABSTRACT
Introduction: COVID-19 is a disease with a wide clinical spectrum, where digestive manifestations can not only accompany, but sometimes precede respiratory symptoms.Objective: to describe the main digestive manifestations in patients with COVID-19.
Methods: a bibliographic review was carried out on the subject, where 31 articles in English and Spanish were consulted, available in the PubMed, Medline, Lilacs, SciELO databases and in the Google Scholar search engine.
Development: despite the fact that most patients with COVID-19 present predominantly respiratory symptoms, some may present digestive manifestations, which is determined by the affinity of SARS-CoV-2 for the angiotensin-converting enzyme 2 (ACE-2) receptor, present on the cell surface of much of the digestive tract and to a lesser extent at the liver level.
Conclusions: digestive manifestations in patients with COVID-19 are relatively common and could be a clinical presentation of the disease. Gastrointestinal symptoms reported have been diarrhea, nausea, vomiting, anorexia, abdominal pain and in some cases digestive bleeding. The hepatogram revealed a mild, transient elevation of transaminases without clinical relevance. In severe cases, hypoalbuminemia has been described, without any other element of liver failure.
REFERENCES
World Health Organization. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 march 2020 [Internet]. 2020 [citado 24 Oct 2021]. [aprox. 3 p.]. Disponible en: https://www.who.int/es/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
Synowiec A, Szczepanski A, Barreto-Duran E, Lie LK, Pyrc K. Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): a systemic infection. Clin Microbiol Rev [Internet]. 2021 [citado 25 Oct 2021];34(2):e00133-20. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849242/pdf/CMR.00133-20.pdf
Rahman S, Villagomez-Montero MT, Rowe K, Kirton R, Kunik F. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol [Internet]. 2021 [citado 25 Oct 2021];14(5):[aprox. 21 p]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095162/pdf/IERJ_0_1902303.pdf
Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int [Internet]. 2020 [citado 27 Oct 2021];40(9):2095–2103. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.14455
Su S, Shen J, Zhu L, Qiu Y, He JS, Tan JY, et al. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. Ther Adv Gastroenterol [Internet]. 2020 [citado 27 Oct 2021];13:1–12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303511/pdf/10.1177_1756284820934626.pdf
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA [Internet]. 2020 [citado 27 Oct 2021];323(13):1239-42. Disponible en: https://jamanetwork.com/journals/jama/articlepdf/2762130/jama_wu_2020_vp_200028.pdf
Sanz-Segura P, Arguedas-Lázaro Y, Mostacero-Tapia S, Cabrera-Chaves T, Sebastián-Domingo JJ. Afectación del aparato digestivo en la covid-19. Una revisión sobre el tema. Gastroenterol Hepatol [Internet]. 2020 [citado 29 Oct 2021];43(8):464–71. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303613/pdf/main.pdf
Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Raymond Liu, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong Cohort: systematic review and meta-analysis. Gastroenterol [Internet]. 2020 [citado 28 Oct 2021];159:81–95. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015300/pdf/WJG-27-1255.pdf
Ghoshal UC, Ghoshal U, Mathur A, Singh RK, Nath A, Garg A, et al. The spectrum of gastrointestinal symptoms in patients with coronavirus disease-19: Predictors, relationship with disease severity, and outcome. Clin Transl Gastroenterol [Internet]. 2020 [citado 29 Oct 2021];11:[aprox. 9p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678797/pdf/ct9-11-e00259.pdf
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol [Internet]. 2020 [citado 30 Oct 2021];115(5):766–73. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172492/pdf/acg-publish_ahead_of_print-10.14309_ajg.0000000000000620.pdf
Chen H, Tong Z, Ma Z, Luo L, Tang Y, Teng Y, et al. Gastrointestinal bleeding, but not other gastrointestinal symptoms, is associated with worse outcomes in COVID-19 patients. Front Med [Internet]. 2021 [citado 30 Oct 2021];8:[aprox. 8p.] Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548414/pdf/fmed-08-759152.pdf
Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, et al. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol [Internet]. 2020 [citado 1 Nov 2021];26(48):7693–7706. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789052/pdf/WJG-26-7693.pdf